BSE filing, NSE: TATVA. Summary written from the filing by ALFA Finder's alert engine.
Tatva Chintan Pharma Chem Ltd: key numbers
- Share price
- ₹1,627.80
- Market cap
- ₹3,808 Cr
- Revenue (annual)
- ₹505.9 Cr
- Net profit (annual)
- ₹42.05 Cr
- P/E (TTM)
- 60.5×Sector 34.1×
- Promoter holding
- 72.02%+0.00% QoQ
- FII holding
- 4.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tatva Chintan Pharma Chem Ltd
All →Tatva Chintan Pharma Chem Investor Presentation: Key Takeaways
Tatva Chintan reported record quarterly revenue of ₹2,173 Mn for Q2 FY27, up 76% YoY, driven by strong SDA demand. EBITDA margins remained flat at 19% due to high solvent costs and freight spikes.
Tatva Chintan Pharma Chem Q2 FY27 Results: Net Profit ₹21.5 Cr, Up 117.2% YoY
Tatva Chintan Pharma Chem Ltd reported revenue from operations of ₹217.3 Cr (+76.0% YoY) and net profit of ₹21.5 Cr (+117.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹21.5 Cr · +117.2% YoY
Tatva Chintan Pharma Chem Other Announcement
The company has filed its quarterly shareholding pattern as per SEBI regulations. This routine disclosure provides details on the current shareholding structure.
Tatva Chintan Pharma Chem Board Meeting Date
Tatva Chintan Pharma Chem has scheduled a Board meeting for 19 October 2026 to consider Q1 FY27 financial results. The trading window will remain closed until 48 hours after results are published.
Tatva Chintan Pharma Chem Annual General Meeting
The company held its 30th Annual General Meeting on September 25, 2026. Shareholders considered and approved items including financial statements and director re-appointments.
Tatva Chintan Pharma Chem Credit Rating
CRISIL Ratings upgraded Tatva Chintan's long-term bank facilities to CRISIL A-/Stable and short-term facilities to CRISIL A2+. This upgrade reflects the company's improved credit profile.
Other board meeting date announcements
All →Shilpa Medicare Board Meeting Date
Shilpa Medicare's board meeting is scheduled for 5 November 2026 to approve Q2 and H1 unaudited financial results. The trading window remains closed until 7 November 2026.
Prakash Woollen & Synthetic Mills Board Meeting Date
Prakash Woollen will hold a board meeting on 06 November 2026 to consider unaudited standalone half-yearly results. Trading window stays closed until 10 November 2026.
Mangal Compusolution Board Meeting Date
Mangal Compusolution has scheduled a board meeting for 03 Nov 2026 to consider H1 FY27 unaudited results. No financial figures or business decisions are disclosed in this advance intimation.
Sharvaya Metals Board Meeting Date
Sharvaya Metals intimates that its Board of Directors is scheduled to meet on 6 November 2026. The agenda includes approval of half-year unaudited results.
Matrimony.com Board Meeting Date
Matrimony.com will hold its board meeting on November 10, 2026, to approve unaudited Q2 and H1 results. Trading window closes October 1 to November 12.
S D Retail Board Meeting Date
S D Retail scheduled a board meeting on 5 Nov 2026 to review half-yearly unaudited results for September 2026. The trading window remains closed until 7 Nov 2026.